Annual Current Liabilities
$4.17 M
-$27.80 K-0.66%
30 September 2022
Summary:
NeuBase Therapeutics annual total current liabilities is currently $4.17 million, with the most recent change of -$27.80 thousand (-0.66%) on 30 September 2022. During the last 3 years, it has fallen by -$27.80 thousand (-0.66%).NBSE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$4.65 M
-$1.47 M-24.06%
30 September 2023
Summary:
NeuBase Therapeutics quarterly total current liabilities is currently $4.65 million, with the most recent change of -$1.47 million (-24.06%) on 30 September 2023.NBSE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -0.7% | +10.9% |
| 5 y5 years | +66.5% | +85.9% |
NBSE Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -32.7% | -34.0% |
NeuBase Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $4.65 M(-24.1%) |
| June 2023 | - | $6.12 M(+218.9%) |
| Mar 2023 | - | $1.92 M(-10.5%) |
| Dec 2022 | - | $2.15 M(-48.5%) |
| Sept 2022 | $4.17 M(-0.7%) | $4.17 M(-0.8%) |
| June 2022 | - | $4.20 M(-15.7%) |
| Mar 2022 | - | $4.99 M(+20.2%) |
| Dec 2021 | - | $4.15 M(-1.1%) |
| Sept 2021 | $4.19 M(+33.2%) | $4.19 M(+33.6%) |
| June 2021 | - | $3.14 M(-11.2%) |
| Mar 2021 | - | $3.54 M(+57.7%) |
| Dec 2020 | - | $2.24 M(-28.8%) |
| Sept 2020 | $3.15 M(+25.9%) | $3.15 M(-9.3%) |
| June 2020 | - | $3.47 M(-6.9%) |
| Mar 2020 | - | $3.73 M(+30.8%) |
| Dec 2019 | - | $2.85 M(+13.9%) |
| Sept 2019 | $2.50 M(+5928.9%) | $2.50 M(+232.8%) |
| June 2019 | - | $751.70 K(+20.3%) |
| Mar 2019 | - | $624.70 K(+4.6%) |
| Dec 2018 | - | $597.20 K(+1339.0%) |
| Sept 2018 | $41.50 K(-99.2%) | $41.50 K(-95.3%) |
| June 2018 | - | $888.40 K(-48.7%) |
| Mar 2018 | - | $1.73 M(-51.9%) |
| Dec 2017 | - | $3.60 M(-27.1%) |
| Sept 2017 | $4.93 M(+10.1%) | $4.93 M(-11.8%) |
| June 2017 | - | $5.59 M(-20.6%) |
| Mar 2017 | - | $7.04 M(+81.2%) |
| Dec 2016 | - | $3.89 M(-13.3%) |
| Sept 2016 | $4.48 M(+15.5%) | $4.48 M(-15.3%) |
| June 2016 | - | $5.29 M(+50.6%) |
| Mar 2016 | - | $3.52 M(-33.4%) |
| Dec 2015 | - | $5.28 M(+36.0%) |
| Sept 2015 | $3.88 M(-26.4%) | $3.88 M(+3.4%) |
| June 2015 | - | $3.75 M(+14.2%) |
| Mar 2015 | - | $3.28 M(-51.5%) |
| Dec 2014 | - | $6.78 M(+28.5%) |
| Sept 2014 | $5.27 M | $5.27 M(-22.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $6.77 M(+639.6%) |
| Mar 2014 | - | $914.90 K(+265.7%) |
| Dec 2013 | - | $250.20 K(-47.8%) |
| Sept 2013 | $479.70 K(-56.0%) | $479.70 K(+88.8%) |
| June 2013 | - | $254.10 K(-20.1%) |
| Mar 2013 | - | $317.90 K(-86.7%) |
| Dec 2012 | - | $2.38 M(+118.5%) |
| Sept 2012 | $1.09 M(-82.4%) | $1.09 M(-54.9%) |
| June 2012 | - | $2.42 M(-7.6%) |
| Mar 2012 | - | $2.62 M(-52.6%) |
| Dec 2011 | - | $5.53 M(-10.8%) |
| Sept 2011 | $6.19 M(+245.2%) | $6.19 M(+1805.4%) |
| June 2011 | - | $325.10 K(-1.8%) |
| Mar 2011 | - | $331.10 K(+2.2%) |
| Dec 2010 | - | $324.00 K(-81.9%) |
| Sept 2010 | $1.79 M(+430.9%) | $1.79 M(+934.3%) |
| June 2010 | - | $173.50 K(-19.0%) |
| Mar 2010 | - | $214.30 K(-42.5%) |
| Dec 2009 | - | $372.60 K(+10.2%) |
| Sept 2009 | $338.00 K(+129.0%) | $338.00 K(-10.1%) |
| June 2009 | - | $376.00 K(-21.7%) |
| Mar 2009 | - | $480.00 K(+235.7%) |
| Dec 2008 | - | $143.00 K(-3.1%) |
| Sept 2008 | $147.60 K(-76.8%) | $147.60 K(-25.8%) |
| June 2008 | - | $199.00 K(-39.0%) |
| Mar 2008 | - | $326.00 K(-48.8%) |
| Sept 2007 | $637.00 K(+1635.7%) | $637.00 K(+305.7%) |
| Mar 2007 | - | $157.00 K(+349.9%) |
| Mar 2006 | - | $34.90 K(-4.9%) |
| Dec 2005 | $36.70 K(-20.0%) | $36.70 K(+23.2%) |
| Sept 2005 | - | $29.80 K(-29.9%) |
| June 2005 | - | $42.50 K(+22.8%) |
| Mar 2005 | - | $34.60 K(-24.6%) |
| Dec 2004 | $45.90 K(-5.0%) | $45.90 K(-4.6%) |
| Sept 2004 | - | $48.10 K(+8.1%) |
| June 2004 | - | $44.50 K(-2.6%) |
| Mar 2004 | - | $45.70 K |
| Dec 2003 | $48.30 K | - |
FAQ
- What is NeuBase Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NeuBase Therapeutics?
What is NeuBase Therapeutics annual total current liabilities?
The current annual current liabilities of NBSE is $4.17 M
What is the all time high annual current liabilities for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual total current liabilities is $6.19 M
What is NeuBase Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of NBSE is $4.65 M
What is the all time high quarterly current liabilities for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly total current liabilities is $7.04 M